Vistagen Therapeutics Inc (NAS:VTGN)
$ 3.03 0.02 (0.66%) Market Cap: 81.98 Mil Enterprise Value: -24.94 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 30/100

Q1 2024 Vistagen Therapeutics Inc Earnings Call Transcript

Aug 10, 2023 / 08:30PM GMT
Release Date Price: $7.52 (+6.82%)
Operator

Greetings, and welcome to the Vistagen Therapeutics Fiscal Year 2024 First Quarter Corporate Update Conference Call. (Operator Instructions) And as a reminder, this conference is being recorded, Thursday, August 10, 2023.

I would now like to turn the conference over to Mark Flather, Vice President of Capital Markets. Please go ahead.

Mark Flather
Vistagen Therapeutics, Inc. - VP of Corporate Strategy & Capital Markets

Thank you, Jennifer. Good afternoon, everyone, and welcome to Vistagen's First Quarter Fiscal Year 2024 Corporate Update Conference Call and Webcast. This afternoon, we issued a press release providing an overview of our progress this last quarter. We encourage you to review this, which can be found on the Investors section of the Vistagen website.

Before starting today, we want to remind you that we may make forward-looking statements regarding our business based on our current expectations and information. The forward-looking statements speak only as of today, and except as required by law, we do not assume any duty to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot